{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:03:52Z","timestamp":1784113432966,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11606-018-4310-4","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T13:14:25Z","timestamp":1518182065000},"page":"471-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries"],"prefix":"10.1007","volume":"33","author":[{"given":"Bruce E.","family":"Landon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan M.","family":"Zaslavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Z.","family":"Ayanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"key":"4310_CR1","volume-title":"National Diabetes Statistics Report, 2014","author":"Centers for Disease Control and Prevention","year":"2014","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2014. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2014."},{"issue":"4","key":"4310_CR2","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2337\/dc12-2625","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033\u201346.","journal-title":"Diabetes Care"},{"key":"4310_CR3","volume-title":"Mean and Median Age at Diagnosis of Diabetes Among Adult Incident Cases Aged 18-79 Years, United States, 1997-2011","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"Centers for Disease Control and Prevention. Mean and Median Age at Diagnosis of Diabetes Among Adult Incident Cases Aged 18-79 Years, United States, 1997-2011. Atlanta, GA: US Department of Health and Human Services; 2015. https:\/\/gis.cdc.gov\/grasp\/diabetes\/DiabetesAtlas.html . Accessed Jan 25 2018."},{"key":"4310_CR4","unstructured":"Chronic Conditions Data Warehouse. Medicare \u2013 CCW Condition Period Prevalence, 2014. 2016."},{"key":"4310_CR5","doi-asserted-by":"publisher","unstructured":"Reusch JE, Manson JE. Management of type 2 diabetes in 2017: getting to goal. JAMA. 2017;317(10)1015\u20136. https:\/\/doi.org\/10.1001\/jama.2017.0241 .","DOI":"10.1001\/jama.2017.0241"},{"issue":"25 Pt B","key":"4310_CR6","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889-934.","journal-title":"J Am Coll Cardiol"},{"key":"4310_CR7","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Standards of medical care in diabetes-2016: Summary of revisions. Diabetes Care. 2016;39(Suppl 1):S4\u20135.","DOI":"10.2337\/dc16-S003"},{"issue":"12","key":"4310_CR8","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/jgs.12035","volume":"60","author":"MS Kirkman","year":"2012","unstructured":"Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012;60(12):2342-56.","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 3","key":"4310_CR9","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/S1262-3636(11)70962-4","volume":"37","author":"AJ Sinclair","year":"2011","unstructured":"Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchasson I, Gadsby R, Rodriguez Manas L. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab. 2011;37(Suppl 3):S27\u201338.","journal-title":"Diabetes Metab"},{"key":"4310_CR10","unstructured":"https:\/\/www.idf.org\/e-library\/guidelines\/78-global-guideline-for-managing-older-people-withtype-2-diabetes.html 2013. Accessed Jan 25 2018."},{"issue":"11","key":"4310_CR11","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1111\/jgs.12513","volume":"61","author":"G Moreno","year":"2013","unstructured":"Moreno G, Mangione CM, Kimbro L, Vaisberg E. Guidelines abstracted from the American Geriatrics Society Guidelines for Improving the Care of Older Adults with Diabetes Mellitus: 2013 update. J Am Geriatr Soc. 2013;61(11):2020-6.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"4310_CR12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.diabres.2014.03.005","volume":"103","author":"T Dunning","year":"2014","unstructured":"Dunning T, Sinclair A, Colagiuri S. New IDF Guideline for managing type 2 diabetes in older people. Diabetes Res Clin Pract. 2014;103(3):538-40.","journal-title":"Diabetes Res Clin Pract"},{"key":"4310_CR13","doi-asserted-by":"crossref","unstructured":"American Diabetes Assocation. 10. Older Adults. Diabetes care. 2015;38(Suppl 1):S67-S9.","DOI":"10.2337\/dc15-S013"},{"issue":"Suppl 1","key":"4310_CR14","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.2337\/dc15-S010","volume":"38","author":"American Diabetes Assocation","year":"2015","unstructured":"American Diabetes Assocation. 7. Approaches to Glycemic Treatment. Diabetes Care. 2015;38(Suppl 1):S41-S8.","journal-title":"Diabetes Care"},{"issue":"22","key":"4310_CR15","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117-28.","journal-title":"N Engl J Med"},{"key":"4310_CR16","doi-asserted-by":"crossref","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375:1834-1844.","DOI":"10.1056\/NEJMoa1607141"},{"issue":"4","key":"4310_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, et al. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. N Engl J Med. 2016;375(4):323-34.","journal-title":"N Engl J Med"},{"issue":"14","key":"4310_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","volume":"369","author":"BM Scirica","year":"2013","unstructured":"Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, et al. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. N Engl J Med. 2013;369(14):1317-26.","journal-title":"N Engl J Med"},{"issue":"3","key":"4310_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJMoa1501352","volume":"373","author":"JB Green","year":"2015","unstructured":"Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, et al. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2015;373(3):232-42.","journal-title":"N Engl J Med"},{"issue":"23","key":"4310_CR20","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","volume":"373","author":"MA Pfeffer","year":"2015","unstructured":"Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Kober LV, et al. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. N Engl J Med. 2015;373(23):2247-57.","journal-title":"N Engl J Med"},{"issue":"14","key":"4310_CR21","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","volume":"369","author":"WB White","year":"2013","unstructured":"White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, et al. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes. N Engl J Med. 2013;369(14):1327-35.","journal-title":"N Engl J Med"},{"issue":"4","key":"4310_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375(4):311-22.","journal-title":"N Engl J Med"},{"key":"4310_CR23","unstructured":"Margolis DJ, Leonard CE, Razzaghi H, Hoffstad OJ, Freeman CP, de Nava KL, et al. Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009: Data Points #9. 2012. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK92702\/#dp9.s1 . Accessed Jan 25 2018."},{"issue":"12","key":"4310_CR24","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1377\/hlthaff.2012.0179","volume":"31","author":"BE Landon","year":"2012","unstructured":"Landon BE, Zaslavsky AM, Saunders RC, Pawlson LG, Newhouse JP, Ayanian JZ. Analysis Of Medicare Advantage HMOs compared with traditional Medicare shows lower use of many services during 2003-09. Health Aff. 2012;31(12):2609-17.","journal-title":"Health Aff"},{"issue":"8","key":"4310_CR25","first-page":"559","volume":"21","author":"BE Landon","year":"2015","unstructured":"Landon BE, Zaslavsky AM, Saunders R, Pawlson LG, Newhouse JP, Ayanian JZ. A comparison of relative resource use and quality in Medicare Advantage health plans versus traditional Medicare. Am J Manag Care. 2015;21(8):559-66.","journal-title":"Am J Manag Care"},{"issue":"7","key":"4310_CR26","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1377\/hlthaff.2012.0773","volume":"32","author":"JZ Ayanian","year":"2013","unstructured":"Ayanian JZ, Landon BE, Zaslavsky AM, Saunders RC, Pawlson LG, Newhouse JP. Medicare beneficiaries more likely to receive appropriate ambulatory services in HMOs than in traditional medicare. Health Aff. 2013;32(7):1228-35.","journal-title":"Health Aff"},{"key":"4310_CR27","unstructured":"Centers for Medicare and Medicaid Services. Chronic Conditions Data Warehouse."},{"key":"4310_CR28","unstructured":"Centers for Medicare and Medicaid Services DoHaHS. Chronic Conditions Data Warehouse home page. https:\/\/www.ccwdata.org\/web\/guest\/home . Accessed Jan 25 2018."},{"key":"4310_CR29","doi-asserted-by":"crossref","unstructured":"Approaches to Glycemic Treatment. Diabetes Care. 2016;39(Suppl 1):S52\u2013S9.","DOI":"10.2337\/dc16-S010"},{"issue":"7","key":"4310_CR30","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1001\/jamainternmed.2014.1824","volume":"174","author":"KJ Lipska","year":"2014","unstructured":"Lipska KJ, Ross JS, Wang Y, Inzucchi SE, Minges K, Karter AJ, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med. 2014;174(7):1116-24.","journal-title":"JAMA Intern Med"},{"key":"4310_CR31","doi-asserted-by":"publisher","unstructured":"American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63(11):2227\u201346. https:\/\/doi.org\/10.1111\/jgs.13702 . Accessed Jan 25 2018.","DOI":"10.1111\/jgs.13702"},{"key":"4310_CR32","unstructured":"American Diabetes Association. New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease. 2014. http:\/\/www.diabetes.org\/newsroom\/press-releases\/2014\/new-standards-of-care-provide-guidelines-forstatin-use-for-people-with-diabetes-to-prevent-heart-disease.html?referrer=https:\/\/www.google.com\/ . Accessed Jan 25 2018."},{"issue":"3 Pt 2","key":"4310_CR33","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/j.1475-6773.2012.01411.x","volume":"47","author":"AM Zaslavsky","year":"2012","unstructured":"Zaslavsky AM, Ayanian JZ, Zaborski LB. The validity of race and ethnicity in enrollment data for Medicare beneficiaries. Health Serv Res. 2012;47(3 Pt 2):1300-21.","journal-title":"Health Serv Res"},{"key":"4310_CR34","unstructured":"Bonito A, Bann C, Eicheldinger C, Carpenter L. Creation of New Race-Ethnicity Codes and Socioeconomic Status (SES) Indicators for Medicare Beneficiaries Final Report. 2008. https:\/\/archive.ahrq.gov\/research\/findings\/final-reports\/medicareindicators\/ . Accessed Jan 25 2018."},{"issue":"10","key":"4310_CR35","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/jama.2016.11698","volume":"316","author":"ME Porter","year":"2016","unstructured":"Porter ME, Lee TH. From Volume to Value in Health Care: The Work Begins. JAMA. 2016;316(10):1047-8.","journal-title":"JAMA"},{"issue":"10","key":"4310_CR36","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2016.12226","volume":"316","author":"VS Lee","year":"2016","unstructured":"Lee VS, Kawamoto K, Hess R, Park C, Young J, Hunter C, et al. Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes and Association With Reduced Cost and Improved Quality. JAMA. 2016;316(10):1061-72.","journal-title":"JAMA"},{"issue":"9","key":"4310_CR37","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1001\/jamainternmed.2015.3533","volume":"175","author":"JX Cai","year":"2015","unstructured":"Cai JX, Campbell EJ, Richter JM. Concordance of Outpatient Esophagogastroduodenoscopy of the Upper Gastrointestinal Tract With Evidence-Based Guidelines. JAMA Intern Med. 2015;175(9):1563-4.","journal-title":"JAMA Intern Med"},{"key":"4310_CR38","unstructured":"Perry Undem Research\/Communication. Unnecessary Tests and Procedures In the Health Care System. ABIM; 2014. http:\/\/www.choosingwisely.org\/wp-content\/uploads\/2015\/04\/Final-Choosing-Wisely-Survey-Report.pdf . Accessed Jan 25 2018."},{"issue":"4","key":"4310_CR39","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMe1607413","volume":"375","author":"JR Ingelfinger","year":"2016","unstructured":"Ingelfinger JR, Rosen CJ. Cardiac and Renovascular Complications in Type 2 Diabetes--Is There Hope? N Engl J Med. 2016;375(4):380-2.","journal-title":"N Engl J Med"},{"issue":"4 Pt 2","key":"4310_CR40","first-page":"6S36","volume":"29","author":"JH Scarpello","year":"2003","unstructured":"Scarpello JH. Improving survival with metformin: the evidence base today. Diabetes Metab. 2003;29(4 Pt 2):6S36\u201343.","journal-title":"Diabetes Metab"},{"issue":"5","key":"4310_CR41","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00125-006-0176-9","volume":"49","author":"JM Evans","year":"2006","unstructured":"Evans JM, Ogston SA, Emslie-Smith A, Morris AD. Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia. 2006;49(5):930-6.","journal-title":"Diabetologia"},{"issue":"12","key":"4310_CR42","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1001\/jamainternmed.2014.5294","volume":"174","author":"SA Berkowitz","year":"2014","unstructured":"Berkowitz SA, Krumme AA, Avorn J, Brennan T, Matlin OS, Spettell CM, et al. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study. JAMA Intern Med. 2014;174(12):1955-62.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"4310_CR43","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2337\/diacare.28.10.2345","volume":"28","author":"DT Eurich","year":"2005","unstructured":"Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care. 2005;28(10):2345-51.","journal-title":"Diabetes Care"},{"issue":"12","key":"4310_CR44","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2337\/diacare.25.12.2244","volume":"25","author":"JA Johnson","year":"2002","unstructured":"Johnson JA, Majumdar SR, Simpson SH, Toth EL. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care. 2002;25(12):2244-8.","journal-title":"Diabetes Care"},{"issue":"3","key":"4310_CR45","doi-asserted-by":"publisher","first-page":"302 e1","DOI":"10.1016\/j.amjmed.2011.07.033","volume":"125","author":"NR Desai","year":"2012","unstructured":"Desai NR, Shrank WH, Fischer MA, Avorn J, Liberman JN, Schneeweiss S, et al. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med. 2012;125(3):302 e1\u20137.","journal-title":"Am J Med"},{"issue":"3","key":"4310_CR46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jama.2016.9400","volume":"316","author":"SC Palmer","year":"2016","unstructured":"Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, et al. Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis. JAMA. 2016;316(3):313-24.","journal-title":"JAMA"},{"issue":"3","key":"4310_CR47","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamainternmed.2014.7345","volume":"175","author":"KJ Lipska","year":"2015","unstructured":"Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015;175(3):356-62.","journal-title":"JAMA Intern Med"},{"issue":"22","key":"4310_CR48","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1001\/jama.2014.6316","volume":"311","author":"KJ Lipska","year":"2014","unstructured":"Lipska KJ, Ross JS, Van Houten HK, Beran D, Yudkin JS, Shah ND. Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010. JAMA. 2014;311(22):2331-3.","journal-title":"JAMA"},{"issue":"13","key":"4310_CR49","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1001\/jama.2016.0126","volume":"315","author":"X Hua","year":"2016","unstructured":"Hua X, Carvalho N, Tew M, Huang ES, Herman WH, Clarke P. Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013. JAMA. 2016;315(13):1400-2.","journal-title":"JAMA"},{"key":"4310_CR50","doi-asserted-by":"crossref","unstructured":"Gomes T, Martins D, Tadrous M, Paterson JM, Shah BR, Tu JV, et al. Association of a Blood Glucose Test Strip Quantity-Limit Policy With Patient Outcomes: A Population-Based Study. JAMA Intern Med. 2016;77(1):61-66.","DOI":"10.1001\/jamainternmed.2016.6851"},{"issue":"2","key":"4310_CR51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/1932296814522808","volume":"8","author":"J Hahamian","year":"2014","unstructured":"Hahamian J. Blood Glucose Test Strip Utilization Within Medicare. J Diabetes Sci Technol. 2014;8(2):429-30.","journal-title":"J Diabetes Sci Technol"},{"key":"4310_CR52","unstructured":"Centers for Medicare and Medicaid Services. Department of Health and Human Services. Contract suppliers selected under medicare competitive bidding program. 2013. https:\/\/www.cms.gov\/Newsroom\/MediaReleaseDatabase\/Press-Releases\/2013-Press-Releases-Items\/2013-04-092.html . Accessed Jan 25 2018."},{"issue":"4","key":"4310_CR53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2337\/dc15-1264","volume":"39","author":"GA Puckrein","year":"2016","unstructured":"Puckrein GA, Nunlee-Bland G, Zangeneh F, Davidson JA, Vigersky RA, Xu L, et al. Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis, Diabetes Care. 2016;39(4):563-71.","journal-title":"Diabetes Care"},{"issue":"12","key":"4310_CR54","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1001\/jamainternmed.2015.5110","volume":"175","author":"JB Sussman","year":"2015","unstructured":"Sussman JB, Kerr EA, Saini SD, Holleman RG, Klamerus ML, Min LC, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus. JAMA Intern Med. 2015;175(12):1942-9.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"4310_CR55","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2337\/dc11-0735","volume":"34","author":"PJ O\u2019Connor","year":"2011","unstructured":"O\u2019Connor PJ, Bodkin NL, Fradkin J, Glasgow RE, Greenfield S, Gregg E, et al. Diabetes performance measures: current status and future directions. Diabetes Care. 2011;34(7):1651-9.","journal-title":"Diabetes Care"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-018-4310-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-018-4310-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-018-4310-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T14:42:57Z","timestamp":1570718577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-018-4310-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["4310"],"URL":"https:\/\/doi.org\/10.1007\/s11606-018-4310-4","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,9]]},"assertion":[{"value":"30 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}